Alexander Cumbo

Alexander Cumbo

President and Chief Executive OfficeratSolid Biosciences· In proxies 2022–2025

Pay in FY2025+7% from the year before · Solid Biosciences stock +41.0% the same year

Alexander Cumbo was paid $5.2M in FY2025 (Dec), up 7%. Solid Biosciences stock rose 41.0% that year.

Pay$100 in the stock at the end of FY21 → $19
Pay is from the Summary Compensation Table of each Solid Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Solid BiosciencesPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -77%
  2. Climb Bio, Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Verve Therapeutics, Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  4. RA Pharmaceuticals, Inc.Public company · 2 yr
    • Director2018 – 2020 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?